New strategies in ovarian cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New strategies in ovarian cancer treatment

Published:2019-12-03 Issue:S24 Volume:125 Page:4623-4629
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lee Jung‐Min¹^ORCID,Minasian Lori²^ORCID,Kohn Elise C.³

Affiliation:

1. Women's Malignancies Branch Center for Cancer Research National Cancer Institute Bethesda Maryland

2. Division of Cancer Prevention National Cancer Institute Bethesda Maryland

3. Gynecologic Cancer Therapeutics, Cancer Therapy Evaluation Program National Cancer Institute Bethesda Maryland

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32544

Reference38 articles.

1. The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications;Duska LR;Ann Oncol,2017

2. Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy;Conic I;J Obstet Gynaecol Res,2015

3. Selumetinib in women with recurrent low‐grade serous carcinoma of the ovary or peritoneum: an open‐label, single‐arm, phase 2 study;Farley J;Lancet Oncol,2013

4. ARID1A mutations in endometriosis‐associated ovarian carcinomas;Wiegand KC;N Engl J Med,2010

5. Mutation and loss of expression of ARID1A in uterine low‐grade endometrioid carcinoma;Guan B;Am J Surg Pathol,2011

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA-based electrochemical biosensors for ovarian cancer;Clinica Chimica Acta;2025-01

2. Mangiferin: An effective agent against human malignancies;Food Science & Nutrition;2024-09-08

3. Synthesis of 1, 2-Disubstituted Benzimidazoles at Ambient Temperature Catalyzed by 1-Methylimidazolium Tetraflouroborate ([Hmim] BF_4) and Investigating Their Anti-ovarian Cancer Properties Through Molecular Docking Studies and Calculations;Qeios;2024-07-29

4. Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma;Journal of Ovarian Research;2024-07-19

5. Drug Repositioning for Ovarian Cancer Treatment: An Update;Anti-Cancer Agents in Medicinal Chemistry;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3